FDA
-
-
-
-
-
-
-
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
-
-
-
-
-
-
-
BriaCell reports extended survival in metastatic breast cancer trial
-
-
-
-
-
-
-
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Reports Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate Cancer
-
-
-
-
-
-
-
BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer
-
330,680 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

